sibutramine
sibutramine is a pharmaceutical drug with 22 clinical trials. Historical success rate of 89.5%.
Success Metrics
Based on 17 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
5
Mid Stage
12
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
89.5%
17 of 19 finished
10.5%
2 ended early
0
trials recruiting
22
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Treatment of Binge Eating in Obese Patients in Primary Care
Studying the Effects of Sibutramine on Eating Behavior
A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese Subjects
Adolescent Weight Management Study
A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects
Clinical Trials (22)
Treatment of Binge Eating in Obese Patients in Primary Care
Studying the Effects of Sibutramine on Eating Behavior
A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese Subjects
Adolescent Weight Management Study
A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects
Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates
Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) Patients
The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS)
A Weight Loss Study in Overweight Men and Women
Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited Genes
Assess the Additional Weight Loss Effect of Orlistat Used in Combination With Sibutramine
Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity
"Efficacy in Adolescents of Continued Behavior Modification Following a Six Month Sibutramine-based Weight Management Intervention"
A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects
Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese Patients
A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects
Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives
Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population
A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.
A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 22